Perspective Therapeutics, Inc. · AMEX:CATX
Commodore Capital LP reported a 9.90% stake in Perspective Therapeutics, Inc. (Schedule 13G)
Event Feb 2, 2026 · Filed Feb 9, 2026
Commodore Capital LP reported a 9.90% stake in Perspective Therapeutics, Inc., 11,939,753 shares, as a passive investor on Feb 2, 2026. Filed Feb 9, 2026 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 11,939,753
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Commodore Capital LP | 9.90% | 11,939,753 |
| Commodore Capital Master LP | 9.90% | 11,939,753 |
| Robert Egen Atkinson | 9.90% | 11,939,753 |
| Michael Kramarz | 9.90% | 11,939,753 |
Source
Related
- Perspective Therapeutics, Inc.
- Commodore Capital LP
- Perspective Therapeutics, Inc. shareholders
- Schedule 13D/A · Lantheus Holdings, Inc. · Sep 23, 2026
- Form 4 · Lantheus Alpha Therapy, LLC · Sep 8, 2026
- Form 4 · Lantheus Holdings, Inc. · Sep 4, 2026
- Form 4 · Lantheus Alpha Therapy, LLC · Sep 4, 2026
- Schedule 13D/A · Lantheus Holdings, Inc. · Sep 4, 2026